BREAKING NEWS: Euro Critic Quits Merkel’s German Coalition in Protest

Bloomberg - Home Search
Celgene Corp (CELG:US)
update Mar 30
120.02 +1.34 (+1.13%)
TODAY
High 120.50
Low 118.96
Open 119.64
Volume 5209247
Time Mar 30
intra-day chart
52 WEEK SUMMARY
High 129.06
Low 66.85
P/E 46.92
Return +71.95%
Mkt Cap 96.087 B
one year chart
Company Profile
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.